Millie
your market intelligence analyst
Search Results
100 results
Your search is now limited to «New Treatments» expert search.
PR Newswire 10/11/2019 02:00
There is a medical need to develop novel anti-NTM drugs because of the long duration of treatment and insufficient treatment outcome of current therapeutics.
More from PR Newswire:
Daiichi Sankyo (Japan) 10/09/2019 11:00
In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders ...
More from Daiichi Sankyo (Japan):
Mitsubishi Tanabe Pharma 10/08/2019 11:00
NMOSD may cause severe muscle weakness and paralysis, loss of vision, respiratory failure, problems with bowel and bladder function and neuropathic pain.1 There is currently no cure or approved treatment for NMOSD.
More from Mitsubishi Tanabe Pharma:
GlobeNewswire 10/07/2019 06:50
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
More from GlobeNewswire:
Company Drug/Device Medical Condition Status Themis Bioscience and ZIKAVAX Second-generation Zika vaccine Zika virus Phase 1 study initiated enrolling 48 healthy subjects Noveome Biotherapeutics, Inc. ST266 intraocular hypertension Phase 1 trial initiated enrolling subjects at the University of Pennsylvania who have been diagnosed with intraocular hypertension who have not yet developed optic nerve damage Clover [...]
Healio News 09/28/2019 19:55
The prospective, randomized, double-blind study assessed efficacy and safety of BackBeat Cardiac Neuromodulation Therapy (Orchestra BioMed Inc.), compared with medical therapy alone, for reducing BP in this challenging population.
More from Healio News:
Business Wire 09/26/2019 13:00
The company currently markets products in several therapeutic areas including anti-infectives, pain, cardiovascular diseases, and gastroenterology.
More from Business Wire:
Pulmonary Hypertension News 09/25/2019 13:30
Translate Bio is focusing its efforts on the development of new therapies targeting pulmonary diseases, including pulmonary arterial hypertension and cystic fibrosis, among others.
More from Pulmonary Hypertension News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications